Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Abraxas Petroleum Corp. (AXAS) Earnings: An Early Look

Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Abraxas Petroleum Corp. (NASDAQ:AXAS) is about to release its quarterly earnings report. The key to making smart investment decisions with stocks releasing their quarter reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Abraxas Petroleum Corp.Abraxas Petroleum Corp. (NASDAQ:AXAS) is a small, independent oil and gas company, with assets scattered across the middle of North America in places including Alberta, the Permian Basin, and the onshore Gulf Coast. Let’s take an early look at what’s been happening with Abraxas Petroleum Corp. (NASDAQ:AXAS) over the past quarter and what we’re likely to see in its quarterly report on Friday.

Stats on Abraxas Petroleum Corp. (NASDAQ:AXAS)

Analyst EPS Estimate ($0.01)
Year-Ago EPS ($0.12)
Revenue Estimate $18.24 million
Change From Year-Ago Revenue 10.9%
Earnings Beats in Past 4 Quarters 1

Source: Yahoo! Finance.

Will Abraxas Petroleum Corp. (NASDAQ:AXAS) generate some energy this quarter?
Analysts have gotten less optimistic about Abraxas Petroleum Corp. (NASDAQ:AXAS)’s earnings prospects in recent months. They’ve worsened their original break-even estimate for the just-ended quarter by a penny per share, and they’ve cut $0.04 per share off their full-year 2013 views. But since early December, the stock has done well, rising 16%.

For years, Abraxas Petroleum Corp. (NASDAQ:AXAS) struggled to break into the big leagues among small independent oil and gas companies. With its assets scattered across North America, it was hard for the company to focus on any one area, despite having promising locations like the Eagle Ford among its holdings.

Last year, though, Abraxas decided to concentrate on the Bakken, spending the bulk of its capital expenditure budget in the area and the nearby Niobrara and seeking to sell off most of its Eagle Ford and Alberta assets. In doing so, Abraxas hopes to follow the same game plan that brought Kodiak Oil & Gas Corp (NYSE:KOG) to profitability, as Kodiak has greatly increased its production from the greater Williston Basin area to send revenue soaring. Northern Oil & Gas, Inc. (NYSEAMEX:NOG) achieved similarly attractive results from its strategy to concentrate in the Bakken.

In the past quarter, Abraxas has had some positive news. Back in November, it doubled its production guidance for 2013, with an implied growth rate of 21%-28%. More recently, Abraxas came out with its operational update last month, showing good growth in oil and gas-liquids reserves during 2012 at the expense of natural-gas capacity.

In its quarterly report, watch for Abraxas to comment on its ongoing transition toward more lucrative oil and liquids, as well as how its chosen wells in the Bakken and its remaining Eagle Ford assets are performing. If all goes well, Abraxas could see some of the same success that has vaulted its peers higher over the years.

The article Abraxas Petroleum Earnings: An Early Look originally appeared on

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!